FDA targets price-gouging drugmakers with plan to import rival products

19th July 2018 Uncategorised 0

If you’re an off-patent drug sitting pretty with no rivals—generic or otherwise—enjoy it while you can. To stir up competition and ease shortages, FDA is looking at importing products approved in other countries but not yet in the U.S.

More: FDA targets price-gouging drugmakers with plan to import rival products
Source: fierce